Cardiology News and Research

Latest Cardiology News and Research

AI model matches high-sensitivity troponin testing in diagnosing heart attacks

An artificial intelligence (AI) model trained to detect blocked coronary arteries based on electrocardiogram (ECG) readings performed better than expert clinicians and was on par with troponin T testing, according to research presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

31 Mar 2025

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.

31 Mar 2025

WARRIOR trial finds no impact of intensive therapy on heart events in women

An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events at five years in women who experienced signs and symptoms of ischemia, or insufficient blood flow to the heart muscle, but had no blockages in their heart's arteries, according to research presented at the American College of Cardiology's Annual Scientific Session.

29 Mar 2025

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major bleeding, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

29 Mar 2025

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and Type 2 diabetes in the first-of-its kind trial to evaluate the use of a GLP-1 agonist to manage PAD.

29 Mar 2025

Study finds 4F-PCC superior to frozen plasma in reducing bleeding after cardiac surgery

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that help the blood clot was significantly more effective and caused fewer adverse effects than frozen plasma, the standard therapy, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

29 Mar 2025

Research reveals optimal duration of dual antiplatelet therapy after stent implantation

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in the months following the procedure.

29 Mar 2025

Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of low-dose apixaban, experienced similar VTE recurrences and less bleeding as similar patients who received a full dose of the oral blood-thinning medication over the same extended period.

29 Mar 2025

Study aims to determine best method for statin prescription in coronary heart disease

A new study by researchers at Intermountain Health in Salt Lake City aims to determine the best method to screen and evaluate patients who are at risk of developing coronary heart disease and which patients would benefit from taking a statin medication to lower cholesterol.

29 Mar 2025

Rivaroxaban shown to be a viable alternative to warfarin for left ventricular thrombus

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar patients who received standard treatment with warfarin, an older blood-thinning drug.

29 Mar 2025

Zero coronary artery calcium score predicts low heart risk at any age

Having a coronary artery calcium (CAC) score of zero has generally been accepted as a marker of a very low risk of having a cardiac event within the next five years. However, age is a strong contributor to coronary risk, with risk increasing markedly as people age.

29 Mar 2025

New ESC consensus statement advances conduction system pacing therapy

The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy.

29 Mar 2025

Ochsner Health study highlights benefits of combination therapy for cardiovascular risks

Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. "Chip" Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious Mayo Clinic Proceedings highlighting the comparative efficacy of lipid-lowering therapies for reducing cardiovascular risks and led by Maciej Banach, MD,PhD from Poland and leader of the International Lipid Expert Panel ( ILEP).

25 Mar 2025

Microplastics exposure linked to increased risk of chronic diseases

Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can be inadvertently consumed or inhaled, is associated with a heightened prevalence of chronic noncommunicable diseases, according to new research being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

25 Mar 2025

Increased mobility linked to lower risk of hospitalization in heart failure patients

Compared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction (HFpEF) who were able to travel outside of their home without assistance were significantly less likely to be hospitalized or die within a year, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

25 Mar 2025

Cardiovascular-related maternal mortality has more than doubled since 1999

The rate of maternal mortality related to cardiovascular causes more than doubled between 1999 and 2022 in the United States, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

25 Mar 2025

New evidence suggests HPV could increase risk of coronary artery disease

In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

25 Mar 2025

Combination therapy could prevent thousands of cardiovascular deaths

The largest analysis to examine the best way to lower levels of 'bad' cholesterol in patients with blocked arteries shows that they should immediately be given a combination of a statin and another drug called ezetimibe, rather than statins alone.

24 Mar 2025

Smartwatch data could offer new way to assess cardiovascular health

The answer to your heart health may be on your wrist, a new study suggests. Researchers have developed a new way to assess cardiovascular health based on information routinely collected by smartwatches, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

20 Mar 2025

Colorectal cancer patients face increased risk of cardiovascular death

People diagnosed with colorectal cancer are significantly more likely to die of cardiovascular causes than the general population, especially in the first two years after their cancer diagnosis and in people younger than 50, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

20 Mar 2025

Previous
1
...
3
4
5
6
7
8
9
...
2494
Next

Cardiology News and Research

Latest Cardiology News and Research

AI model matches high-sensitivity troponin testing in diagnosing heart attacks

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

WARRIOR trial finds no impact of intensive therapy on heart events in women

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Study finds 4F-PCC superior to frozen plasma in reducing bleeding after cardiac surgery

Research reveals optimal duration of dual antiplatelet therapy after stent implantation

Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients

Study aims to determine best method for statin prescription in coronary heart disease

Rivaroxaban shown to be a viable alternative to warfarin for left ventricular thrombus

Zero coronary artery calcium score predicts low heart risk at any age

New ESC consensus statement advances conduction system pacing therapy

Ochsner Health study highlights benefits of combination therapy for cardiovascular risks

Microplastics exposure linked to increased risk of chronic diseases

Increased mobility linked to lower risk of hospitalization in heart failure patients

Cardiovascular-related maternal mortality has more than doubled since 1999

New evidence suggests HPV could increase risk of coronary artery disease

Combination therapy could prevent thousands of cardiovascular deaths

Smartwatch data could offer new way to assess cardiovascular health

Colorectal cancer patients face increased risk of cardiovascular death

Innovation in neuroscience drug discovery - eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Cardiology News and Research

Latest Cardiology News and Research

Innovation in neuroscience drug discovery - eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in